Biotech RadarJobs updated

COMPANY

VM Oncology

vmoncology.com ↗

Clinical Phase 2

Profile checked Oct 10, 2026

Keywords: Head and Neck Carcinoma Adenoid Cystic Carcinoma Lung Cancer Non-Small Cell Lung Cancer Pancreatic Cancer Mesothelioma Esophageal Cancer Any Solid Tumors Progressed After a Prior Immunotherapy Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma HNSCC Salivary Gland Carcinomas Head and Neck Cancers - Salivary Gland Head and Neck Cancers - Nasopharyngeal Head and Neck Cancers - Throat Small Cell Lung Cancer Lung Cancer (Locally Advanced or Metastatic) Head and Neck Cancers - Tonsils Head and Neck Cancers Hypopharynx Head and Neck Cancers Larynx Head and Neck Cancers Lip Head and Neck Cancers Nasopharynx Head and Neck Cancers Oral Cavity Head and Neck Cancers Head and Neck Cancers Oropharynx Head and Neck Cancers Trachea VMD-928

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT03556228VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPhase 1/Phase 2RecruitingJun 8, 20182027-12 (estimated)
Feedback